Alira Health

Alira Health

Corporate Strategy for a Biotech Company with a Diversified Portfolio

Reports
Category:
Published on:
April 1, 2020
Written by:
Joris Pezzini

When our client, a leader in the biopharmaceuticals space, needed support to assess their company’s competitive position and determine areas of growth and focus, the Alira Health team developed an in-depth scientific and commercial assessment covering the biopharma industry. See how this work focused our client on the most critical areas, helping them to marshall their resources and move forward with confidence.

For more information, please contact Joris Pezzini.

For more information about Alira Health’s Management Consulting services

Learn more

Related news

Events July 18, 2024
UXN Health 2024
Look for patient engagement expert Eduardo Perez onsite in Aarhus to connect on topics like integrating patient voices in solution design.
Co-Design MedTech Patient Engagement Pharma
Case Studies March 26, 2024
Pharma Company Overcomes Launch Challenges with Patient-Centric Strategy
Our patient engagement team helped this pharma client identify the drivers behind the challenges they faced with their product launch.
Patient Centricity Patient Engagement Pharma
Case Studies March 12, 2024
Pharma Company Adopts a Patient-Centric Value Proposition for Regulatory and Payer Dossier
A pharma company had a wealth of patient data on a product in development and they wanted to create a long-term strategy that would create a continuity of patient engagement across(...)
Patient Centricity Patient Engagement Pharma
News February 7, 2024
Alira Health Advises Aesculapius Farmaceutici Srl in Its Acquisition by Ceres Pharma NV
We are pleased to have represented as transaction advisor Aesculapius, a leading Italian pharmaceutical company active in the development and distribution of prescription drugs, OTC(...)
Pharma Transaction Advisory
News January 26, 2024
Alira Health’s CDD Supports Alcami Acquisition of Pacific Pharmaceutical Services
We are pleased to have been an advisor on Alcami’s acquisition of Pacific Pharmaceutical Services (PPS). Alira Health advised Alcami, a leading Contract Development Manufacturing(...)
CDD CDMO Pharma
Events January 22, 2024
Pharmapack Europe
Connect with our Drug Delivery Systems and CDMO experts Aude Ouensanga, Giulia Valsecchi, and Michal Raciborski on site at Pharmapack Europe.
CDMO Drug Delivery Pharma
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.